Through trial and research, USDTL has recently added two new analytes to its test menu.

Buprenorphine, as analyzed in meconium, urine, breast milk and umbilical cord

Unexplained incidence of neonatal abstinence syndrome (NAS) could be caused by pregnant women using diverted buprenorphine, a synthetic opiod used to treat narcotic addiction, to avoid withdrawal symptoms. Abuse of buprenorphine has become a growing problem in recent years. In 2008, USDTL received concerns from hospitals about pregnant women using buprenorphine and the lack of buprenorphine on standard opiate drug tests. In 2009, USDTL launched the buprenorphine add-on assay to any MecStat^SM, UrineStat^SM, Breast Milk and CordStat^SM profile.

Ketamine, as analyzed in urine and hair

Ketamine is marketed as a general anesthetic for human and veterinary use. However, because of its dissociative properties, ketamine is diverted for recreational use and has become a popular date rape and club drug. USDTL now offers a ketamine add-on assay to any UrineStat^SM, HairStat^SM and NailStat^SM profile.

For further information about these tests and their pricing call 1-800-235-2367 and ask for Sales.